News

Search here results

• New ovarian cancer drug based on UCL research | UCL Cancer Institute - UCL – University College London
• Immunotherapy discovery a step towards treating T cell cancers | UCL Cancer Institute - UCL – University College London
• Tumour Heterogeneity Team wins Cancer Research UK Translational Cancer Research Prize 2017 | UCL Cancer Institute - UCL – University College London
• Osimertinib shows promise as new standard-of-care treatment for advanced lung cancer | UCL Cancer Institute - UCL – University College London
• Experimental model to study the development of brain cancer in children | UCL Cancer Institute - UCL – University College London
• First patient treated with microscopic beads pre-loaded with a targeted cancer drug | UCL Cancer Institute - UCL – University College London
• Rucaparib boosts progression-free survival in recurrent ovarian cancer | UCL Cancer Institute - UCL – University College London
• First prostate cancer patient scanned using hyperpolarised MRI in Europe | UCL Cancer Institute - UCL – University College London
• Professor Adrienne Flanagan awarded OBE in Queen’s Birthday Honours | UCL Cancer Institute - UCL – University College London
• Existing drugs could benefit patients with bone cancer, genetic study suggests | UCL Cancer Institute - UCL – University College London